Pharmaceutical - Tropical diseases

Filter

Current filters:

Tropical diseases

Popular Filters

1 to 25 of 54 results

Bayer collaborates with DNDi on novel, oral human river blindness treatment

09-12-2014

German pharma major Bayer and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement…

Astellas PharmaBayeremodepsidePharmaceuticalResearchTropical diseases

European Union's response to Ebola emergency

18-11-2014

West Africa is currently facing the largest and most complex Ebola epidemic on record. Guinea, Liberia…

Anti-viralsFinancialPharmaceuticalResearchRest of the WorldTropical diseases

Hilleman Labs signs MoU to fast track development of high-impact oral cholera vaccine

14-11-2014

Hilleman Laboratories, an equal joint-venture partnership between US pharma major Merck & Co and the…

Asia-PacificHilleman LaboratoriesIncepta VaccineMerck & CoPharmaceuticalResearchTropical diseasesVaccinesWELLCOME TRUST

US lawmakers introduce Bill to speed Ebola treatments development

30-10-2014

Two US Senators have announced their intention to introduce a bill to speed the development of treatments…

Anti-viralsLegalPharmaceuticalResearchTropical diseasesUSAVaccines

Inovio Pharma’s Ebola vaccine moving into Ph I with GeneOne Life Science

24-09-2014

US drug developer Inovio Pharmaceuticals has said it will advance its DNA vaccine for Ebola into a Phase…

GeneOne Life ScienceInovio PharmaceuticalsPharmaceuticalResearchTropical diseasesVaccines

Ebola vaccine trials fast-tracked by international consortium, including GSK

Ebola vaccine trials fast-tracked by international consortium, including GSK

28-08-2014

In the wake of the devastating outbreak of Ebola in West Africa, an unprecedented international consortium…

At preventing the diseaseBiologyDiseaseEbola epidemicGlaxoSmithKlineMedicinePharmaceuticalResearchTropical diseasesVaccines

Novartis signs agreement with TB Alliance for development of its tuberculosis compounds

Novartis signs agreement with TB Alliance for development of its tuberculosis compounds

20-08-2014

Swiss drug major Novartis has signed an exclusive global licensing agreement with the Global Alliance…

Antibiotics and Infectious diseasesNovartisPharmaceuticalResearchSwitzerlandTB AllianceTropical diseasesTuberculosis

Globavir to seek approval and launch of novel Ebola treatment by year-end

Globavir to seek approval and launch of novel Ebola treatment by year-end

19-08-2014

Privately-held US biotech firm Globavir Biosciences said yesterday that it intends to develop its lead…

Antibiotics and Infectious diseasesGBV006Globavir BiosciencesMarkets & MarketingPharmaceuticalRegulationRest of the WorldTropical diseasesUSA

Ethical considerations for use of unregistered interventions for Ebola viral disease

Ethical considerations for use of unregistered interventions for Ebola viral disease

12-08-2014

In reaction to West Africa is experiencing the largest, most severe and most complex outbreak of Ebola…

Anti-viralsClinical researchHealthcarePharmaceuticalRegulationRest of the WorldTropical diseases

GSK files EU regulatory submission for RTS,S malaria vaccine candidate

24-07-2014

UK pharma giant GlaxoSmithKline announced today that it has submitted a regulatory application to the…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRest of the WorldRTS,STropical diseasesVaccines

Fast growth forecast for dengue vaccine market

Fast growth forecast for dengue vaccine market

18-07-2014

Among the five major pharmaceutical markets (5MM: Brazil, India, Mexico, Singapore and Thailand), Brazil…

Asia-PacificBrazilMarkets & MarketingMexicoPharmaceuticalResearchTropical diseases

GSK gains EU marketing OK for Incruse for COPD; initiates tafenoquine Ph III program

GSK gains EU marketing OK for Incruse for COPD; initiates tafenoquine Ph III program

29-04-2014

UK pharma giant GlaxoSmithKline has received marketing authorization from the European Commission for…

EuropeGlaxoSmithKlineIncrusePharmaceuticalRespiratory and PulmonarytafenoquineTropical diseases

Japan’s Eisai joins forces with UK researchers on tropical disease research

Japan’s Eisai joins forces with UK researchers on tropical disease research

20-03-2014

Japanese drug major Eisai has entered a collaboration with the UK’s Liverpool School of Tropical Medicine…

EisaiPharmaceuticalResearchTropical diseases

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

31-01-2014

Belgium-based VIB, a non-profit research institute in life sciences, and the Center for Drug Design and…

Asia-PacificAstraZenecaIndiaInflammatory diseasesOncologyPharmaceuticalResearchTropical diseases

Takeda collaboration with Medicines for Malaria Venture

Takeda collaboration with Medicines for Malaria Venture

26-12-2013

Japan’s largest drugmaker Takeda Pharmaceutical has entered into agreements with Medicines for Malaria…

DSM265ELQ300PharmaceuticalResearchTakeda PharmaceuticalsTropical diseases

FDA “Breakthrough Therapy” designation for GSK’s malaria drug tafenoquine; EU Cervarix news

FDA “Breakthrough Therapy” designation for GSK’s malaria drug tafenoquine; EU Cervarix news

22-12-2013

The US Food and Drug Administration has granted “Breakthrough Therapy” designation for tafenoquine,…

CervarixEuropeGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationtafenoquineTropical diseases

IFPMA and the Global Fund collaborate to help protect patients from fake medicines

05-12-2013

The International Federation of Pharmaceutical Manufacturers and Associations and the Global Fund to…

Anti-viralsAntibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalRegulationTropical diseases

Novartis researchers identify new drug target for malaria

Novartis researchers identify new drug target for malaria

28-11-2013

Scientists at Swiss pharma major Novartis have discovered a new drug target for treating malaria, with…

NovartisPharmaceuticalResearchTropical diseases

New malaria vaccines roadmap targets next generation products by 2030

New malaria vaccines roadmap targets next generation products by 2030

14-11-2013

The world should aim to have vaccines which reduce malaria cases by 75%, and are capable of eliminating…

HealthcarePharmaceuticalResearchRest of the WorldTropical diseasesVaccines

US FDA delays approval of Paladin’s Impavido

US FDA delays approval of Paladin’s Impavido

12-11-2013

Canada-based specialty pharmaceutical company Paladin Labs says that the US Food and Drug Administration…

ImpavidoNorth AmericaPaladin LabsPharmaceuticalRegulationTropical diseases

Eisai enters agreement to develop treatments for neglected tropical diseases

Eisai enters agreement to develop treatments for neglected tropical diseases

11-11-2013

Eisai (TYO: 4523) has entered into a global agreement with the Broad Institute to jointly discover and…

Asia-PacificEisaiNorth AmericaPharmaceuticalResearchTropical diseases

Vaccine confers long-term protection against cholera

17-10-2013

A clinical study published in the Lancet Infectious Diseases demonstrates for the first time that an…

PharmaceuticalSanofiShanthaTropical diseasesVaccines

1 to 25 of 54 results

Back to top